EVO - What's Going On With Life Science Company Evotec Stock Today? | Benzinga
Evotec SE (NASDAQ: EVO) joined forces with the Crohn's & Colitis Foundation to advance drug discovery and identify novel therapies for inflammatory bowel disease (IBD). No financial terms of the collaboration were disclosed.
This initiative translates academic research identified by the Foundation into healthcare solutions.
This partnership utilizes Evotec's R&D platform to enhance drug development for two novel drug targets aimed at significant ...